ライフサイエンスコーパス: bloodstream infection

1 to be linked with the risk of contracting a bloodstream infection.

2 in flora-related, or central line-associated bloodstream infection.

3 rt of clinical care of patients with candida bloodstream infection.

4 % (43 of 123 patients) for patients with CRE bloodstream infection.

5 in-flora-related, or central-line-associated bloodstream infection.

6 phi and 9 (1.3%) with Salmonella Paratyphi A bloodstream infection.

7 and black patients, and in the setting of a bloodstream infection.

8 h CSE bloodstream infection and 123 with CRE bloodstream infection.

9 e intestine, increasing a patient's risk for bloodstream infection.

10 genetic loci linked to risk of contracting a bloodstream infection.

11 uitable treatment in patients with S. aureus bloodstream infection.

12 mia, but TLR2(-/-)mice could still resolve a bloodstream infection.

13 83 for intra-abdominal infection and 45 for bloodstream infection.

14 llowing: pocket infection; endocarditis; and bloodstream infection.

15 estinal malignancy, yet are also isolated in bloodstream infection.

16 te UMH9, which was recovered from a clinical bloodstream infection.

17 s thromboembolism or central-line associated bloodstream infection.

18 an promote host protection against S. aureus bloodstream infection.

19 , enabling replication that can seed intense bloodstream infection.

20 ciated with protection against gram-negative bloodstream infection.

21 tant exhibits a severe fitness defect during bloodstream infection.

22 esponses, which collectively protect against bloodstream infections.

23 rbapenem-resistant Entero-bacteriaceae (CRE) bloodstream infections.

24 nces in management with mortality in candida bloodstream infections.

25 or the most commonly identified organisms in bloodstream infections.

26 mine a worse outcome both in respiratory and bloodstream infections.

27 tion about the role of PhoQ in P. aeruginosa bloodstream infections.

28 ention decreased mortality for patients with bloodstream infections.

29 improved clinical outcomes for patients with bloodstream infections.

30 nts with less frequent Gram-negative bacilli bloodstream infections.

31 surface decolonisation reduced all-pathogen bloodstream infections.

32 t (ICU) patients may affect catheter-related bloodstream infections.

33 tant clone associated with urinary tract and bloodstream infections.

34 the 2 most prevalent Candida species causing bloodstream infections.

35 omising approach for combating P. aeruginosa bloodstream infections.

36 tles in pediatric patients with a concern of bloodstream infections.

37 hich is critical for successful treatment of bloodstream infections.

38 onset (CO) and hospital-onset (HO) suspected bloodstream infections.

39 theters (hazard ratio [HR] for time to first bloodstream infection 0.71, 95% CI 0.37-1.34).

40 P < .001) and more frequently manifested as bloodstream infection (31% vs 6%; P = .002).

41 lity, we analysed 1691 patients with candida bloodstream infection; 776 (45.9%) who had an infectious

42 Intensive care unit cost per bloodstream infection accounted for the largest share of

43 An outbreak of 162 Bcc bloodstream infections across 59 nursing facilities in 5

44 cloacae isolated between 2001 and 2011 from bloodstream infections across hospitals in the UK and Ir

45 ound three loci with a suggestive linkage to bloodstream infection, all on chromosome 4, at 46.6 cent

46 remain the leading cause of catheter-related bloodstream infection, although an increase in Gram-nega

47 Salmonella Typhi was the leading cause of bloodstream infection among infants and young children <

48 from 16 sites in ten countries: 174 with CSE bloodstream infection and 123 with CRE bloodstream infec

49 um samples from 30 children with a bacterial bloodstream infection and 35 children with Plasmodium fa

50 % (35 of 174 patients) for patients with CSE bloodstream infection and 35% (43 of 123 patients) for p

51 We report long-term trends in bloodstream infection and antimicrobial resistance from

52 ous infections usually arise from an initial bloodstream infection and are frequently recalcitrant to

53 To compare catheter-related bloodstream infection and colonization risk between the

54 roorganisms associated with catheter-related bloodstream infection and colonization was significantly

55 Salmonella (NTS) isolated from persons with bloodstream infection and diarrheal disease from 2007 th

56 d Salmonella Typhimurium are major causes of bloodstream infection and diarrheal disease in East Afri

57 al of 314 propensity score-matched S. aureus bloodstream infection and in 268 E. coli bloodstream inf

58 ne prophylaxis was associated with decreased bloodstream infection and intestinal colonization by gra

59 nomic analysis of E. faecium associated with bloodstream infection and isolated from wastewater.

60 epidemic, using temporal trends in S. Typhi bloodstream infection and perforated abdominal viscus at

61 with higher rates of central-line associated bloodstream infection and venous thromboembolism than ce

62 o be associated with central-line associated bloodstream infection and venous thromboembolism were in

63 of antimicrobial therapy targeted toward CPE bloodstream infections and assist infection control and

64 cation of Gram-negative organisms that cause bloodstream infections and can significantly impact pati

65 s, with hypercapsule mutants associated with bloodstream infections and capsule-deficient mutants ass

66 anemia, intermittent proteinuria, recurrent bloodstream infections and chronic pulmonary disease.

67 (ICUs) resulted in greater reductions in all bloodstream infections and clinical isolates of methicil

68 enous catheter and arterial catheter-related bloodstream infections and colonization according to the

69 ated clinical infection syndromes (including bloodstream infections and community-acquired pneumonia)

70 Bloodstream infections and invasive nontyphoidal Salmone

71 r severe and often deadly infections such as bloodstream infections and pneumonia.

72 have tremendous impact on the management of bloodstream infections and sepsis.

73 lications, including central-line associated bloodstream infections and venous thromboembolism.

74 rtile range, 9-36 days), 61% of patients had bloodstream infection, and 59% died.

75 spp. causing illness, describe non-Brucella bloodstream infections, and identify risk factors for br

76 dida albicans is a leading cause of systemic bloodstream infections, and synthesis of the phospholipi

77 us infections account for 15 to 50% of fatal bloodstream infections annually.

78 We sought to describe Salmonella bloodstream infections, antimicrobial resistance, and ag

79 Bloodstream infections are a leading cause of morbidity

80 Fungal bloodstream infections are a significant problem in the

81 Salmonella enterica bloodstream infections are an important cause of childho

82 Even with surgical and antibiotic therapy, bloodstream infections are associated with significant m

83 Infections acquired overseas and bloodstream infections are particularly important areas

84 Bloodstream infections are very rare for COVID-19 patien

85 , 0.29 [95% CI, 0.10-0.82]; P = .02) and new bloodstream infection (ARR, 0.05 [95% CI, 0.00-0.09]; RR

86 wastewater with 187 isolates associated with bloodstream infection at five hospitals in the East of E

87 exidine (CHG) bathing decreases incidence of bloodstream infections at intensive care units, but its

88 The primary outcome was time to first bloodstream infection between 48 h after randomisation a

89 al center in New York City who had S. aureus bloodstream infections between 1 January 2007 and 31 Dec

90 th increased incidence of and mortality from bloodstream infection (BSI) and sepsis.

91 s for vancomycin-resistant enterococci (VRE) bloodstream infection (BSI) are limited.

92 ital, a retrospective cohort of adult KPC-KP bloodstream infection (BSI) cases (January 2014 to Decem

93 tibiotic treatment for lower UTI and risk of bloodstream infection (BSI) in adults aged >=65 years in

94 icenter prospective study of all episodes of bloodstream infection (BSI) in high-risk FN patients (20

95 MRSA bloodstream infection (BSI) incidence per 100 000 popula

96 We examined P. aeruginosa bloodstream infection (BSI) isolates for the ability to

97 prediction models have been shown to predict bloodstream infection (BSI) likelihood in this populatio

98 t of vancomycin-resistant Enterococcus (VRE) bloodstream infection (BSI) on outcomes of allogeneic he

99 007-2017) of hospital-based Salmonella Typhi bloodstream infection (BSI) surveillance in the Democrat

100 ed a DOOR endpoint for Staphylococcus aureus bloodstream infection (BSI) through a survey to infectio

101 Bloodstream infection (BSI) to due vancomycin-resistant

102 Little is known of the long-term risks of bloodstream infection (BSI) with extended spectrum beta-

103 Hospital-associated sepsis, bloodstream infection (BSI), and mortality (>3 days afte

104 fficile infection (CDI) is a risk factor for bloodstream infection (BSI).

105 rtality of patients with liver cirrhosis and bloodstream infection (BSI).

106 vancomycin dosing on patient outcome in MRSA bloodstream infection (BSI); (2) defining, testing, and

107 Candida bloodstream infections (BSI) are associated with signifi

108 organism identification improves outcomes in bloodstream infections (BSI) but have not controlled for

109 ital, a retrospective cohort of adult KPC-KP bloodstream infections (BSI) cases (January 2014 to Dece

110 in etiologies and susceptibility patterns of bloodstream infections (BSI) in hospitalized children in

111 eatment with DAP alone in patients with MRSA bloodstream infections (BSI).

112 ith K. aerogenes versus Enterobacter species bloodstream infections (BSI).

113 Bloodstream infections (BSI-SA) and noninvasive coagulas

114 ndida and multidrug-resistant (MDR) bacteria bloodstream infections (BSIs) and their crude death rate

115 in hospital-onset (HO) Staphylococcus aureus bloodstream infections (BSIs) and used whole-genome sequ

116 Bloodstream infections (BSIs) cause significant morbidit

117 ), yet the prevalence of IE in patients with bloodstream infections (BSIs) caused by different strept

118 Rapid diagnostic tests (RDTs) for bloodstream infections (BSIs) decrease the time to organ

119 nation therapy on mortality of patients with bloodstream infections (BSIs) due to CPE.

120 ta-lactamase inhibitors for the treatment of bloodstream infections (BSIs) due to extended-spectrum b

121 Yet, its impact on MRSA bloodstream infections (BSIs) has not been well studied.

122 We investigated Bcc bloodstream infections (BSIs) in a cohort of non-CF pati

123 the treatment of gram-negative bacilli (GNB) bloodstream infections (BSIs) in patients presenting wit

124 f blood culture (BC) volume for detection of bloodstream infections (BSIs) is documented.

125 herapy within 48 hours of Enterobacteriaceae bloodstream infections (BSIs) on 90-day risk of CDI.

126 To determine the magnitude of bloodstream infections (BSIs) related to their use, PubM

127 as notified by hospital A of 3 patients with bloodstream infections (BSIs) with a rapidly growing non

128 otified by Hospital A of three patients with bloodstream infections (BSIs) with a rapidly growing, no

129 d cultures, the gold standard for diagnosing bloodstream infections (BSIs), are insensitive and limit

130 critically needed for Staphylococcus aureus bloodstream infections (BSIs), particularly for methicil

131 ly demonstrate improved clinical outcomes in bloodstream infections (BSIs).

132 for multidrug-resistant Enterococcus faecium bloodstream infections (BSIs).

133 Cs) are the standard method for diagnosis of bloodstream infections (BSIs).

134 robes are an important but uncommon cause of bloodstream infections (BSIs).

135 eatment with DAP alone in patients with MRSA bloodstream infections (BSIs).

136 tor of early mortality risk in patients with bloodstream infections (BSIs).

137 theters are recommended for adults to reduce bloodstream infections but not for children because ther

138 neutropenia, likely bacterial infection, and bloodstream infection by >/=70%.

139 and could help to optimize therapy early in bloodstream infections by CPE.

140 We show here that the R domain enables bloodstream infections by directing fibrinogen to the st

141 Bloodstream infections by Salmonella enterica serovar Ty

142 of Community acquired Staphylococcus aureus bloodstream infection (CA-SABSI) with myocardial infarct

143 S. aureus bloodstream infection cases and controls were equally ma

144 biotics, previous antibiotic exposure, index bloodstream infection caused by either rGNB or Candida s

145 ics, previous antibiotic exposure, and index bloodstream infection caused by either rGNB or Candida s

146 The possibility of bloodstream infections caused by 3rd-generation cephalos

147 patients with sepsis or septic shock due to bloodstream infections caused by GNB admitted between 20

148 Bloodstream infections caused by nontyphoidal Salmonella

149 can identify patients at risk for subsequent bloodstream infections caused by resistant bacteria.

150 can identify patients at risk for subsequent bloodstream infections caused by resistant bacteria.

151 acetylsalicylic acid therapy on mortality in bloodstream infections caused by S. aureus compared with

152 on-typhoidal Salmonella (iNTS), are seasonal bloodstream infections causing important morbidity and m

153 luate differences in central line-associated bloodstream infection (CLABSI) rates by how central line

154 Central line-associated bloodstream infection (CLABSI) remains prevalent in hosp

155 uce the incidence of central line-associated bloodstream infection (CLABSI).

156 fections (CAUTI) and central line-associated bloodstream infections (CLABSI) per 1000 device days.

157 Central line-associated bloodstream infections (CLABSIs) often result from intra

158 he incidence of VTE, central line-associated bloodstream infections (CLABSIs), and catheter malfuncti

159 ealthcare-associated central line-associated bloodstream infections (CLABSIs), using National Healthc

160 catheters significantly reduced the risk of bloodstream infections compared with standard and hepari

161 both in terms of intestinal colonization and bloodstream infections, compared with non-prophylaxed pa

162 lently for 30 isolates derived from clinical bloodstream infections, confirming system optimization f

163 in severe sepsis/septic shock, patients with bloodstream infection could be discriminated by a decrea

164 better understanding of the microbiology of bloodstream infections could improve outcomes.

165 linically diagnosed sepsis, catheter-related bloodstream infection (CRBSI), and all-cause mortality.

166 r complications of HPN were catheter-related bloodstream infections (CRBSIs) (1.7/1000 d of PN) and i

167 Little is known about catheter-related bloodstream infections (CRBSIs) in this population.

168 e parenteral support (HPS), catheter-related bloodstream infections (CRBSIs) inflict health impairmen

169 re independent, thus saving precious time in bloodstream infection diagnostics.

170 ed assay can rapidly detect F. tularensis in bloodstream infections directly in whole blood at the ea

171 d its impact on the outcome of patients with bloodstream infection due to Enterobacteriaceae (BSI-E).

172 spital stay among inpatients in LMICs with a bloodstream infection due to Enterobacteriaceae.

173 with an increased risk for catheter-related bloodstream infection due to nonfermenting Gram-negative

174 swabs of their environment, together with 1 bloodstream infection during the study and 4 others over

175 ropriate antibiotic therapy for enterococcal bloodstream infections (EBSI) can be delayed.

176 nesis has primarily focused on pneumonia and bloodstream infections, even though one in five A. bauma

177 In two patients, an attenuated toxicity bloodstream infection evolved from an asymptomatically c

178 obiota is connected to risk of gram-negative bloodstream infections, expanding on our prior work in t

179 Patients with Candida bloodstream infection experienced a prior marked intesti

180 Current evidence on catheter-related bloodstream infection femoral risk, compared with the ot

181 aches to identify patients at risk of fungal bloodstream infections for pre-emptive therapeutic inter

182 total hospital costs decreased by $2,439 per bloodstream infection, for an approximate annual cost sa

183 centre, aged 18 years or older with candida bloodstream infection from 2002 to 2015.

184 eillance of Salmonella Typhi and Paratyphi A bloodstream infections from 5 October 2015 through 4 Oct

185 es transitioning patients with gram-negative bloodstream infections from intravenous to oral therapy

186 with daptomycin plus a beta-lactam for MRSA bloodstream infection had lower odds of composite clinic

187 Hospital-acquired bloodstream infections have a definite impact on patient

188 he primary endpoint in patients with E. coli bloodstream infection (hazard ratio, 0.78; 95% CI, 0.40-

189 aureus (MRSA) is a frequent cause of lethal bloodstream infection; however, vaccines and antibody th

190 ous catheters (CVCs) reduce catheter-related bloodstream infection in adults and children receiving i

191 of staphylococci and for protection against bloodstream infection in animals.

192 cin-resistant Enterococcus (VRE), leading to bloodstream infection in hospitalized patients.

193 uring intestinal colonization and subsequent bloodstream infection in immunocompromised pediatric pat

194 During bloodstream infection in mice, DARC targeting by S. aure

195 ial burden and inflammation during S. aureus bloodstream infection in mice.

196 ontributing to the lethality observed during bloodstream infection in mice.

197 ith two or more second-degree relatives with bloodstream infection in the follow-up period.

198 lso available for E. faecium associated with bloodstream infections in 15 patients in neighboring hos

199 standard central venous catheters to prevent bloodstream infections in children needing intensive car

200 bial-resistant S. marcescens associated with bloodstream infections in hospitals across the United Ki

201 nd 2018, there was an associated rise in VRE bloodstream infections in hospitals where contact precau

202 ine (CHG) bathing decreases the incidence of bloodstream infections in intensive care units, but its

203 on reduces multidrug-resistant pathogens and bloodstream infections in intensive care units.

204 hospital stay and mortality in patients with bloodstream infections in LMICs.

205 phoid and paratyphoid remain the most common bloodstream infections in many resource-poor settings.

206 eate the impact of propofol sedation on MRSA bloodstream infections in mice in the presence and absen

207 4 most common gram-negative bacteria causing bloodstream infections in neutropenic patients.

208 central venous catheters could help prevent bloodstream infections in paediatric intensive care unit

209 The identification of 4 Bcc bloodstream infections in patients residing at a single

210 the predominant cause of community-acquired bloodstream infections in sub-Saharan Africa (sSA).

211 In order to prevent the bloodstream infections in the neonates, it is indispensa

212 estinal colonization is highly predictive of bloodstream infection, in the setting of allo-HCT.

213 lso been developed detecting the presence of bloodstream infections including electrochemical, potent

214 Bacterial bloodstream infection is a common cause of morbidity and

215 Bacteremia or bloodstream infection is a frequent and costly complicat

216 Bloodstream infection is an important cause of death wor

217 Staphylococcus aureus bloodstream infection is associated with considerable mo

218 Bloodstream infection is associated with high mortality

219 Candida bloodstream infection is associated with high mortality.

220 sion, these data suggest that S. epidermidis bloodstream infection is cleared in a highly efficient m

221 Mortality in MSSA bloodstream infection is declining, associated with a de

222 be considered if a femoral catheter-related bloodstream infection is suspected.

223 Bloodstream infection is the most severe, with mortality

224 Research on S. aureus bloodstream infections is a frontier for the characteriz

225 Identification of bloodstream infections is among the most critical tasks

226 Bacteremia (bacterial bloodstream infection) is a major cause of illness and d

227 mia, one of the most common causes of fungal bloodstream infection, leads to mortality rates up to 40

228 am isolate showed that the subject's E. coli bloodstream infection likely originated from the intesti

229 iated with male sex, central line-associated bloodstream infections, long-term acute care hospitals,

230 We hypothesized that septic patients with bloodstream infections may transition across states char

231 hospital-onset multidrug-resistant organism bloodstream infection (MDRO-BSI) and Clostridium diffici

232 ted in a strain that was acutely virulent in bloodstream infection models in mice and in ex vivo mode

233 Among patients with CRGNB bloodstream infections (n=319) overall 30- and 90-day mo

234 ong central venous catheter catheter-related bloodstream infection, nonfermenting Gram-negative bacil

235 Bloodstream infection occurred in 18 (4%) of those in th

236 sed association with central-line associated bloodstream infection (odds ratio, 0.505; 95% CI, 0.336-

237 cal infections of >0.3/1,000 patient days or bloodstream infections of >0.03/1,000 patient days shoul

238 on profiles of 9,215 P. vivax parasites from bloodstream infections of Aotus and Saimiri monkeys.

239 treated with curative intent at the time of bloodstream infection onset.

240 No significant differences in bloodstream infections or laboratory alterations were re

241 The development of bloodstream infection (OR: 18.76; 95% CI: 1.04-339.37; p

242 or equal to median was associated with fewer bloodstream infections (OR, 0.67 [95% CI, 0.45-0.98).

243 gdom identified 342 patients with E. faecium bloodstream infection over 7 years.

244 regression to examine trends in icidence of bloodstream infection over time.

245 es in children should focus on prevention of bloodstream infections, particularly among neonates and

246 ate earlier optimization of the treatment of bloodstream infections, particularly in conjunction with

247 eus bloodstream infection and in 268 E. coli bloodstream infection patients, respectively (1:1 match

248 1,000 line days) and central-line associated bloodstream infection (peripherally inserted central cat

249 ma; any ICU-acquired infection; ICU-acquired bloodstream infection, pneumonia, and urinary tract infe

250 Neonatal sepsis is a bloodstream infection primarily caused by Escherichia co

251 the early host response to S. aureus during bloodstream infection, promoting enhanced responses by b

252 next-generation sequencing-based analyses of bloodstream infections provide a valuable diagnostic pla

253 ent conditions increased risk of PVC-related bloodstream infection (PVCR-BSI).

254 Incident bloodstream infection rate was 9.6 and 8.4 per 1000 hosp

255 n the post-Directive central line-associated bloodstream infection rates associated with a unit incre

256 Patients with candida bloodstream infection receiving an infectious disease co

257 Bloodstream infections remain a major cause of morbidity

258 ty of America definition of catheter-related bloodstream infection remains the most precise definitio

259 l fungi (that is, the mycobiota) with fungal bloodstream infections remains undefined(9).

260 Gram-negative bloodstream infections represent a significant complicat

261 inical S. aureus isolates from patients with bloodstream infections, representing two globally import

262 ed pneumonia, intra-abdominal infections and bloodstream infections, respectively.

263 ano-mupirocin in a murine model of S. aureus bloodstream infection resulted in improved antibiotic di

264 racteristics were excluded, catheter-related bloodstream infection risk was comparable between the si

265 Catheter-related bloodstream infection risk was comparable for internal j

266 an may, similarly, decrease catheter-related bloodstream infection risk, when compared with femoral.

267 Clinical trials for Staphylococcus aureus bloodstream infections (SAB) are broadly grouped into 2

268 events were febrile neutropenia (22 [66%]), bloodstream infections (six [16%]), and invasive fungal

269 lmonella isolates from African patients with bloodstream infections, spanning 1966 to 2018.

270 Klebsiella pneumoniae causes severe lung and bloodstream infections that are difficult to treat due t

271 of MRSA, highlight the growing challenge of bloodstream infections that are effectively impossible t

272 , however, at high risk for catheter-related bloodstream infections that can result in substantial mo

273 site infections, and 2 versus 0 for primary bloodstream infection; the effect was consistent across

274 esistant Enterococcus (VRE) and ICU-acquired bloodstream infection (UABSIs) were analysed from 1,189,

275 sistant Enterococcus (VRE), and ICU-acquired bloodstream infections (UABSIs) for 1 189 142 patients f

276 teria was used as predictor of gram-negative bloodstream infection using Cox proportional hazards mod

277 ssue infection, urinary tract infection, and bloodstream infection varied among the 3 sites.

278 omes (ICU mortality, central line-associated bloodstream infection, ventilator-associated pneumonia,

279 Vancomycin-resistant Enterococcus bloodstream infections (VRE-BSIs) are associated with si

280 The total hospital cost per bloodstream infection was lower in the intervention grou

281 The NPV for bloodstream infections was 96.5%, for intra-abdominal cu

282 The NPV for bloodstream infections was 96.5%, for intraabdominal cul

283 The rate of catheter-related bloodstream infections was higher in the early-strategy

284 lis is a natural heme auxotroph and cause of bloodstream infection, we explored whether restoration o

285 rapid identification of Escherichia coli in bloodstream infections, we employed an existing colorime

286 f 4967 unique patients with Enterobacterales bloodstream infections, we sought to answer the question

287 A total of 480 patients with bloodstream infections were included in the analysis: 24

288 Bloodstream infections were increased in patients with v

289 cal blood culture samples from patients with bloodstream infections were incubated for 1 h with the "

290 Bloodstream infections were the most common type of infe

291 s activating protease in the pathogenesis of bloodstream infection, which indicates a greater complex

292 al domination was associated with subsequent bloodstream infection, which was observed overall and in

293 strategies for the pathogenesis of S. aureus bloodstream infections, which culminate in the establish

294 Candidemia is a common healthcare-associated bloodstream infection with high morbidity and mortality.

295 eviated oxidative stress in our rat model of bloodstream infection with MRSA.

296 Brucella spp. was the most common bloodstream infection, with B. melitensis isolated from

297 d genetic intermixing between wastewater and bloodstream infection, with highly related isolates shar

298 to how VREfm adapted during colonization and bloodstream infection within each patient.

299 -resistant urinary tract infection (UTI) and bloodstream infection worldwide.

300 is the single most prevalent cause of fungal bloodstream infections worldwide causing significant mor